Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf Gedeborg

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 17, 2010
Autoantibodies to cardiac troponin in acute coronary syndromesBertil Lindahl, Per Venge, Kai M Eggers, et al.
Scandinavian Journal of Urology|November 13, 2023
Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in SwedenRolf Gedeborg, Fredrik Sandin, Camilla Thellenberg-Karlsson, et al.
Pharmacoepidemiology and Drug Safety|December 17, 2022
Federated analyses of multiple data sources in drug safety studiesRolf Gedeborg, Wilmar Igl, Bodil Svennblad, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 23, 2011
Prediction of fracture risk in men: a cohort studyLiisa Byberg, Rolf Gedeborg, Thomas Cars, et al.
JAMA|October 22, 2009
Cardiovascular diseases and risk of hip fractureUlf Sennerby, Håkan Melhus, Rolf Gedeborg, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Long-term dietary vitamin D intake and risk of fracture and osteoporosis: a longitudinal cohort study of Swedish middle-aged and elderly womenGreta Snellman, Liisa Byberg, Eva Warensjö Lemming, et al.
European Urology Open Science|June 19, 2026
Long-term Outcomes in Men with Stable PSA During 5-α Reductase Inhibitor Therapy After Negative Prostate Biopsy: Population-based StudyEugenio Ventimiglia, Marcus Westerberg, Andri Wilberg Orasson, et al.
Acta Oncologica (Stockholm, Sweden)|April 15, 2026
Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in SwedenArmando Galdieri, Hans Garmo, Rolf Gedeborg, et al.
Scandinavian Journal of Urology|February 4, 2026
Consequences of different definitions of disease progression in observational studies of men with advanced prostate cancerEugenio Ventimiglia, Marcus Westerberg, Paolo Zaurito, et al.
Acta Oncologica (Stockholm, Sweden)|February 19, 2021
Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in SwedenGincy George, Hanna Vikman, Rolf Gedeborg, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 17, 2010
Autoantibodies to cardiac troponin in acute coronary syndromesBertil Lindahl, Per Venge, Kai M Eggers, et al.
Scandinavian Journal of Urology|November 13, 2023
Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in SwedenRolf Gedeborg, Fredrik Sandin, Camilla Thellenberg-Karlsson, et al.
Pharmacoepidemiology and Drug Safety|December 17, 2022
Federated analyses of multiple data sources in drug safety studiesRolf Gedeborg, Wilmar Igl, Bodil Svennblad, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 23, 2011
Prediction of fracture risk in men: a cohort studyLiisa Byberg, Rolf Gedeborg, Thomas Cars, et al.
JAMA|October 22, 2009
Cardiovascular diseases and risk of hip fractureUlf Sennerby, Håkan Melhus, Rolf Gedeborg, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Long-term dietary vitamin D intake and risk of fracture and osteoporosis: a longitudinal cohort study of Swedish middle-aged and elderly womenGreta Snellman, Liisa Byberg, Eva Warensjö Lemming, et al.
European Urology Open Science|June 19, 2026
Long-term Outcomes in Men with Stable PSA During 5-α Reductase Inhibitor Therapy After Negative Prostate Biopsy: Population-based StudyEugenio Ventimiglia, Marcus Westerberg, Andri Wilberg Orasson, et al.
Acta Oncologica (Stockholm, Sweden)|April 15, 2026
Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in SwedenArmando Galdieri, Hans Garmo, Rolf Gedeborg, et al.
Scandinavian Journal of Urology|February 4, 2026
Consequences of different definitions of disease progression in observational studies of men with advanced prostate cancerEugenio Ventimiglia, Marcus Westerberg, Paolo Zaurito, et al.
Acta Oncologica (Stockholm, Sweden)|February 19, 2021
Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in SwedenGincy George, Hanna Vikman, Rolf Gedeborg, et al.
Pageof 9